Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Entheon Biomedical Corp
C.ENBI
Alternate Symbol(s):
ENTBF
Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:ENBI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(6)
•••
jerryfurberules
X
View Profile
View Bullboard History
Post by
jerryfurberules
on Mar 18, 2024 4:02pm
reverse split
another one bites the dust.
(128)
•••
Tslayer
X
View Profile
View Bullboard History
Post by
Tslayer
on Dec 01, 2023 2:37pm
Update
Anyone know if Entheon is still in business? Web site is gone. I did call 3 numbers in Vancouver listed on line and 2 of the numbers were disconnected. I did reach VM on 3rd number and person said
...more
Energy Co Unveils Q3 2024 Results: Record Growth & Strategic Expansion
posted Nov 21, 2024 9:00am by
Coelacanth Energy Inc.
-
|
In Q3 2024, Coelacanth started the construction of its planned $80.0 million infrastructure project that includes over 35 kilometers of pipelines and a facility to handle current behind pipe volumes and future expansions. Ultimately the facility will be able to handle approximately 16,000 boe/d of which Coelacanth has approximately 4,400 boe/d tested but shut-in at the 5-19 Two Rivers East pad ...read more
(6)
•••
jerryfurberules
X
View Profile
View Bullboard History
Post by
jerryfurberules
on Dec 19, 2022 1:54pm
Oh oh
website now gone.
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Feb 27, 2022 3:58pm
Entheon Biomedical Announces EBIQ-101 First-Patient Dose
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biomedical
...more
(36)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on Nov 08, 2021 4:02pm
Excellent YT analysis on Entheon Biomed
https://youtu.be/6MmeuwtsCqo
(6)
•••
jerryfurberules
X
View Profile
View Bullboard History
Post by
jerryfurberules
on Oct 29, 2021 2:05pm
Progress
Patient recruitment in progress, steady as she goes! The benifits and personal statements of success in the news.
(10)
•••
Viralstocks1
X
View Profile
View Bullboard History
Post by
Viralstocks1
on Oct 27, 2021 11:47am
Corporate Update on Studies and Clinical Trials
News Release (27-10-21): Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials. Read here: https://finance.yahoo.com/news/entheon-biomedical-provides-corporate-studies-120000726
...more
(119)
•••
Hopeful123
X
View Profile
View Bullboard History
Post by
Hopeful123
on Oct 25, 2021 2:51pm
Long at 80 cts
Any hope left..What is their cash position..will they last another year til the market hopefully turns around.
(128)
•••
Tslayer
X
View Profile
View Bullboard History
Comment by
Tslayer
on Oct 21, 2021 3:21pm
RE:Have a great feeling..
$30,000 @ $0.93. Ouch! I hope you're licking your wounds. How low will this drop? I have an order in at $0.20. I think I will get it by year end. The Sprott investment did the exact opposite of
...more
(10)
•••
Viralstocks1
X
View Profile
View Bullboard History
Post by
Viralstocks1
on Aug 24, 2021 1:04pm
Entheon Biomedical Corp. Announces DTC Eligibility
News Release (24-08-21): Entheon Biomedical Corp. Announces DTC Eligibility. Read here: https://entheonbiomedical.com/investors/#press-releases
(10)
•••
Viralstocks1
X
View Profile
View Bullboard History
Post by
Viralstocks1
on Jun 22, 2021 4:08pm
Announces Agreement with Third Wave.
News Release (22-06-21): Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave. Read Here: https://www.thewhig.com/newsfile/88229-entheon-biomedical-subsidiary
...more
(10)
•••
Viralstocks1
X
View Profile
View Bullboard History
Post by
Viralstocks1
on Jun 16, 2021 3:23pm
Agreement to Acquire Lobo Genetics Inc.
News Release (16-06-21): Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.. Read here: https://www.marketscreener.com/quote/stock/ENTHEON-BIOMEDICAL-CORP-43256782/news/Entheon
...more
(10)
•••
Viralstocks1
X
View Profile
View Bullboard History
Post by
Viralstocks1
on Jun 10, 2021 1:48pm
Psychedelics Genetic Test Kit Now Available for Sale in US
News Release (10-06-21): Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US. Read Here: https://stockhouse.com/news
...more
(35)
•••
iSPYgains
X
View Profile
View Bullboard History
Post by
iSPYgains
on Mar 17, 2021 1:01pm
Entheon Interview Just Posted on YouTube!
Link: https://www.youtube.com/watch?v=xBNhORKwFBU
(52)
•••
nopoo
X
View Profile
View Bullboard History
Post by
nopoo
on Feb 27, 2021 7:00pm
Video Interview with Timothy Ko
Video Interview with Timothy Ko, CEO of Entheon Biomedical aheadoftheherd.com/aoth-media/video-interview-with-timothy-ko-ceo-of-entheon-biomedical/ https://
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >